Robert G. Klimasewski

VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY.

Part of Pfizer Inc., VirtualScopics New York LLC is a company that provides advanced image-based biomarker analytic technology and services. The company is based in Pittsford, NY. VirtualScopics New York was acquired by Pfizer Inc. on July 22, 2002.

Lumetrics, Inc. develops and manufactures precision thickness measurement and gauging systems. It offers precision thickness and geometric measurements for various materials and products, such as multilayer films and materials, flat films, coatings, medical balloons, tubing, glass, contact lenses, and roll stock. The company was founded by Todd F. Blalock, Christopher T. Cotton, John Hart, Steve Heveron-Smith in 2002 and is headquartered in Rochester, NY.

University Technology Seed Fund LLC, a joint venture between Trillium Group and the University of Rochester, seeks to invest in companies located in the US with new inventions and discoveries which offer high potential for commercial success. The fund focuses on companies operating in the fields of technology including health, medical, & biotech, optics & photonics, electronics, engineering & materials and IT & communications. It provides financing for seed and early stage capital requirements with an investment range from $0.25 to $1 million.